TIGIT and cancer: Accumulating data from the immune monitoring of cancer patients have revealed that TIGIT expression is elevated in T and NK cells, and it often appears to be associated with advanced disease status and poor clinical outcomes [34,35,48,49,50,51,52,53,54,55,56,57,58].